PHT Corporation announced that it has selected Dell Venue 11 Pro tablets featuring Windows 8.1
PHT Corporation, provider of technologies for collecting patient-driven electronic data, announced that it has selected Dell Venue 11 Pro tablets featuring Windows 8.1 to run its SitePad System.The SitePad System is used in clinical trials to collect clinician- and patient-reported outcomes for supporting label claims of new therapies.
PHT has purchased more than 2,000 Dell Venue 11 Pros, which will be deployed at clinical trial sites around the globe.
Read the full release here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Real-World Data Show 99% Efficacy for Apretude in HIV Prevention with High Adherence, Reduced Stigma
October 16th 2024Real-world data presented at IDWeek 2024 show Apretude (cabotegravir long-acting) is more than 99% effective in preventing HIV infection, with high adherence rates, reduced stigma and anxiety, and broad acceptability.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.